Fig. 2.

Optical coherence tomography alterations post ocriplasmin use. A 62-year-old male with VMT of the right eye (a). Following intravitreal injection of ocriplasmin, VMT was released (b) at day 7. Ellipsoid layer attenuation and accumulation of subretinal fluid was present (arrows) and vision decreased from 20/50 at baseline to 20/80. Ellipsoid layer changes and subretinal fluid progressively resolved as shown at day 30 (c), day 60 (d), and day 90 (e). Visual acuity was 20/25 on day 60 and was maintained through the follow-up period thereafter